plerixafor has been researched along with cyclam in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boquet, I; Kraus, JL; Laras, Y; Moret, V; Norreel, JC; Rolland, A | 1 |
| Bridger, GJ; Gerlach, LO; Schwartz, TW; Skerlj, RT | 1 |
| Liang, X; Sadler, PJ | 1 |
| Bridger, GJ; Gerlach, LO; Hatse, S; Rosenkilde, MM; Schols, D; Schwartz, TW; Skerlj, RT | 1 |
| Archibald, SJ; Greenman, J; Khan, A | 1 |
| Budd, L; Collins, A; Covelli, D; De Clercq, E; Kennepohl, P; Pannecouque, C; Parsons, S; Robertson, N; Ross, A; Sadler, PJ; Soares, DC | 1 |
| Borrell, JI; Clotet, B; Esté, JA; Mena, MP; Pérez-Nueno, VI; Pettersson, S; Teixidó, J | 1 |
| Bhattacharya, S; Hall, SE; Lam, AR; Mao, A; Patel, K; Vaidehi, N | 1 |
2 review(s) available for plerixafor and cyclam
| Article | Year |
|---|---|
Cyclam complexes and their applications in medicine.
Topics: Animals; Anti-HIV Agents; Benzylamines; Cyclams; Heterocyclic Compounds; HIV-1; HIV-2; Humans; Inhibitory Concentration 50; Metals; Molecular Conformation; Nitric Oxide Donors; Radiopharmaceuticals; Stereoisomerism; Superoxide Dismutase | 2004 |
Small molecule CXCR4 chemokine receptor antagonists: developing drug candidates.
Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Benzylamines; Chemokine CXCL12; Chemokines; Cyclams; Heterocyclic Compounds; HIV Infections; Humans; Neoplasms; Receptors, CXCR4; Structure-Activity Relationship | 2007 |
6 other study(ies) available for plerixafor and cyclam
| Article | Year |
|---|---|
Discovery of new small molecules that influence neuroblast cell migration from the subventricular zone.
Topics: Animals; Aza Compounds; Cell Movement; Disulfides; Drug Design; Lateral Ventricles; Macrocyclic Compounds; Mice; Neurons; Peptides, Cyclic; Polyamines | 2008 |
Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.
Topics: Amino Acid Sequence; Animals; Anti-HIV Agents; Antiviral Agents; Asparagine; Aspartic Acid; Benzylamines; Binding, Competitive; Chemokine CXCL12; Chemokines, CXC; COS Cells; Cyclams; DNA, Complementary; Heterocyclic Compounds; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Linear Models; Models, Chemical; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Binding; Protein Conformation; Receptors, CXCR4; Transfection | 2001 |
Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor.
Topics: Amino Acid Sequence; Animals; Anti-HIV Agents; Antibodies, Monoclonal; Benzylamines; Chlorocebus aethiops; COS Cells; Cyclams; Heterocyclic Compounds; Humans; Molecular Sequence Data; Mutation; Pyridines; Receptors, CXCR4 | 2007 |
Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.
Topics: Anti-HIV Agents; Benzylamines; Cell Proliferation; Crystallography, X-Ray; Cyclams; Drug Screening Assays, Antitumor; Heterocyclic Compounds; HIV-1; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Organometallic Compounds; Receptors, CXCR4; Structure-Activity Relationship; Tumor Cells, Cultured; Vanadates | 2010 |
Novel monocyclam derivatives as HIV entry inhibitors: Design, synthesis, anti-HIV evaluation, and their interaction with the CXCR4 co-receptor.
Topics: Benzylamines; Cell Line; Cyclams; Drug Design; Heterocyclic Compounds; HIV; HIV Fusion Inhibitors; Humans; Molecular Dynamics Simulation; Protein Binding; Receptors, CXCR4 | 2010 |
Importance of receptor flexibility in binding of cyclam compounds to the chemokine receptor CXCR4.
Topics: Allosteric Regulation; Amino Acid Sequence; Benzylamines; Binding Sites; Copper; Cyclams; Heterocyclic Compounds; Humans; Models, Molecular; Molecular Sequence Data; Protein Binding; Protein Conformation; Pyridines; Receptors, CXCR4 | 2011 |